| MONDAY, May 23 |
| 11 am – 1 pm |
Registration Open
|
| |
Workshop Series #1:
Nano Business Liabilities
Financial Center Ballroom
2nd Flr
As the business of nanotech matures, it is beginning to encounter a plethora of legal, ethical and social challenges. In this series of seminars, some of the leading thinkers in risk, ethics and toxicology discuss these issues and present potential roadmaps for dealing with them. |
Workshop Series #2:
Nano Business Building
Grand Ballroom
2nd Flr
Growing nanotechnology companies need well-developed corporate growth strategies that often require interaction with government, academic and international entities. In this series of workshops, experts explain how small companies can engage government and academia to help grow their businesses. |
1 – 1:55 pm
|
Insurance, Risk and Nanotechnologies |
Chasing Government Funding for Private Companies |
| 2:05 – 3 pm |
The Science and Ethics of Nanotechnology
|
Challenges and Opportunities in University-Industry Partnerships
|
| 3 – 3:30 pm |
Coffee Break
|
Coffee Break
|
| 3:30 – 4:30 pm |
Is It Safe?:
Toxicology and Nanotechnology
|
International Trade Administration: Utilizing ITA Commercial Services for International Business Development
|
| 4:45 – 5:15 pm |
KEYNOTE
ADDRESS
Grand Ballroom
|
| 5:20 – 6 pm |
KEYNOTE ADDRESS
Grand Ballroom |
| 6 pm |
Cocktail Reception
|
| |
| TUESDAY, May 24 |
| 8 – 8:30 am |
Breakfast
|
| 8:30 – 9:15 am |
OPENING KEYNOTE: Jeff Jaffe, President, Bell Labs |
| 9:30 – 10:45 am |
BREAKOUT Session #1:
Exit Strategies
Grand Ballroom
Merger? Acquisition? IPO? Nanotech business has entered a phase of consolidation—or has it? What’s the best exit strategy for a nanotech company? How do you make that decision? In this session, executives from nanotech companies that have pursued different exit strategies discuss their experiences, what they did right, and what they did wrong. |
BREAKOUT Session #2: TBD
Financial Center Ballroom
|
| 11 am – 12:15 pm |
PANEL SESSION: Nanotech Firsts
As in anything, trails must be blazed by pioneers. In this session, some of the entrepreneurs who were the first to reach important milestones (the first company to have a nano-enabled formula approved by FDA, the first to …) discuss their experiences. |
| 12:15 – 2 pm |
Lunch and Visit Exhibit Hall
|
| 2 – 3 pm |
PANEL SESSION: Systems Integration
Nanotech products are rarely stand-alone: they are integrated into other systems. For nanotech companies, integrating their products into other systems is often as big a challenge as getting the product ready in the first place. In this session, business leaders from some of the largest end users of nanotechnologies talk about the state of systems integration, roadblocks and bottlenecks in the pipeline, and the outlook for the future.
|
| 3:15 – 4:30 pm |
BREAKOUT Session #3: Strategies for Monetizing Nanotech Patents
Grand Ballroom
The nanotech patenting flurry continues to grow at exponential rates. But how does a university or a company actually make money from their intellectual property? This session gets away from legal nuts and bolts of IP to focus on the business side, with speakers from both the university nanotech licensing arena and large corporate patent departments.
|
BREAKOUT Session #4: Security and Nanotechnology
Financial Center Ballroom
Security and defense are early adopters of advanced nanotechnologies and a plethora of companies are already providing products to DoD, DHS and even foreign military and civilian security forces. In this session, some of these companies present their businesses and products, from encryption, to biodetection and weapons systems.
|
| 4:45 – 5:30 pm |
KEYNOTE ADDRESS: Dr. Ann Barker, VP for Industry Relations, National Cancer Institute
|
| 5:30 – 7 pm |
Networking Reception
|
| |
| WEDNESDAY, May 25 |
| 8 – 8:30 am |
Breakfast
|
| 8:30 – 9:15 am |
KEYNOTE ADDRESS (Financial)
|
| 9:30 – 10:45 am |
BREAKOUT Session #5 TBD
Grand Ballroom
|
BREAKOUT Session #6 TBD
Financial Center Ballroom
|
| 11 am – 12:15 pm |
PANEL SESSION: 2005-2007 Nanotech Economic Outlook
With the US economy making a slow recovery and global markets remaining hesitant, what is the real economic outlook for nanotech? What are the manufacturing and workforce trends that will drive or inhibit growth? What are the global economic and social issues that need to be taken account of? In this session, a panel of leading economic thinkers considers the realities of the global economic outlook for nanotech.
|
| 12:15 – 2 pm |
Lunch and Visit Exhibit Hall
|
| 2 – 2:45 pm |
KEYNOTE ADDRESS
|
| 3 – 4pm |
PANEL SESSION: Ask the Experts
In this free-flowing panel, audience members will have the opportunity to ask pointed questions from a panel of conference keynotes and speakers. By bringing together experts from across the spectrum of issues discussed throughout the conference, this panel will (we hope) create some controversy, some argument, and offer some new perspective on the nanotech landscape. |
| 4 pm |
Conference Concludes
|
